Quantitative and mechanism-based investigation of post-nuclear delivery events between adenovirus and lipoplex

Nucleic Acids Research

Volumn 35, Issue 5, 2007, Pages 1533-1543

  Hama, Susumu ^a,c   Akita, Hidetaka ^a,c   Iida, Shinya ^a   Mizuguchi, Hiroyuki ^b   Harashima, Hideyoshi ^a,c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GENOMIC DNA; LIPOFECTAMINE; LIPOPLEX; LIPOSOME; MESSENGER RNA; PLASMID DNA;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DNA HYBRIDIZATION; GENE EXPRESSION; GENE INTERACTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA TRANSLATION; TRANSGENE;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOVIRIDAE; CELL LINE; CELL NUCLEUS; DNA; DNA, VIRAL; GENETIC VECTORS; HELA CELLS; HUMANS; LIPIDS; MICROSCOPY, CONFOCAL; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSGENES;

ADENOVIRIDAE;

EID: 34247112229     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl1165     Document Type: Article

References (42)

1. Dinser,R., Kreppel,F., Zaucke,F., Blank,C., Paulsson,M., Kochanek,S. and Maurer,P. (2001) Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes. Histochem. Cell. Biol., 116, 69-77.
2. Hama,S., Akita,H., Ito,R., Mizuguchi,H., Hayakawa,T. and Harashima,H. (2006) Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol. Ther., 13, 786-794.
3. Marshall,E. (1999) Gene therapy death prompts review of adenovirus vector. Science, 286, 2244-2245.
4. Hacein-Bey-Abina,S., von Kalle,C., Schmidt,M., Le Deist,F., Wulffraat,N., McIntyre,E., Radford,I., Villeval,J.L., Fraser,C.C. et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med., 348, 255-256.
5. Parker,A.L., Newman,C., Briggs,S., Seymour,L. and Sheridan,P.J. (2003) Nonviral gene delivery: Techniques and implications for molecular medicine. Expert Rev. Mol. Med., 2003, 1-15.
6. Kamiya,H., Akita,H. and Harashima,H. (2003) Pharmacokinetic and pharmacodynamic considerations in gene therapy. Drug Discov. Today 8, 990-996.
7. Akita,H., Ito,R., Khalil,I.A., Futaki,S. and Harashima,H. (2004) Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy. Mol. Ther., 9, 443-451.
8. Varga,C.M., Tedford,N.C., Thomas,M., Klibanov,A.M., Griffith,L.G. and Lauffenburger,D.A. (2005) Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes. Gene. Ther., 12, 1023-1032.
9. Masuda,T., Akita,H. and Harashima,H. (2005) Evaluation of nuclear transfer and transcription of plasmid DNA condensed with protamine by microinjection: The use of a nuclear transfer score. FEBS Lett., 579, 2143-2148.
10. Mizuguchi,H., Koizumi,N., Hosono,T., Utoguchi,N., Watanabe,Y., Kay,M.A. and Hayakawa,T. (2001) A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther., 8, 730-735.
11. Moriguchi,R., Kogure,K., Iwasa,A., Akita,H. and Harashima,H. (2006) Non-linear pharmacodynamics in a non-viral gene delivery system: positive non-linear relationship between dose and transfection efficiency. J. Control Release, 110, 605-609.
12. Iwasa,A., Akita,H., Khalil,I., Kogure,K., Futaki,S. and Harashima,H. (2006) Cellular uptake and subsequent intracellular trafficking of R8-liposomes introduced at low temperature. Biochim. Biophys. Acta 1758, 713-720.
13. Sharp,P.A., Moore,C. and Haverty,J.L. (1976) The infectivity of adenovirus 5 DNA-protein complex. Virology, 75, 442-456.
14. Akita,H., Tanimoto,M., Masuda,T., Kogure,K., Hama,S., Ninomiya,K., Futaki,S. and Harashima,H. (2006) Evaluation of the nuclear delivery and intra-nuclear transcription of plasmid DNA condensed with micro (mu) and NLS-micro by cytoplasmic and nuclear microinjection: A comparative study with poly-L-lysine. J. Gene. Med., 8, 198-206.
15. Keller,M., Harbottle,R.P., Perouzel,E., Colin,M., Shah,I., Rahim,A., Vaysse,L., Bergau,A., Moritz,S. et al. (2003) Nuclear localisation sequence templated nonviral gene delivery vectors: Investigation of intracellular trafficking events of LMD and LD vector systems. Chembiochem., 4, 286-298.
16. Rux,J.J. and Burnett,R.M. (2004) Adenovirus structure. Hum. Gene. Ther., 15, 1167-1176.
17. Lee,T.W., Blair,G.E. and Matthews,D.A. (2003) Adenovirus core protein VII contains distinct sequences that mediate targeting to the nucleus and nucleolus, and colocalization with human chromosomes. J. Gen. Virol., 84, 3423-3428.
18. Lee,T.W., Lawrence,F.J., Dauksaite,V., Akusjarvi,G., Blair,G.E. and Matthews,D.A. (2004) Precursor of human adenovirus core polypeptide Mu targets the nucleolus and modulates the expression of E2 proteins. J. Gen. Virol., 85, 185-196.
19. Matthews,D.A. (2001) Adenovirus protein V induces redistribution of nucleolin and B23 from nucleolus to cytoplasm. J. Virol., 75 1031-1038.
20. Okuwaki,M., Matsumoto,K., Tsujimoto,M. and Nagata,K. (2001) Function of nucleophosmin/B23, a nucleolar acidic protein, as a histone chaperone. FEBS Lett., 506, 272-276.
21. de Jong,R.N., Mysiak,M.E., Meijer,L.A., van der Linden,M. and van der Vliet,P.C. (2002) Recruitment of the priming protein pTP and DNA binding occur by overlapping Oct-1 POU homeodomain surfaces. EMBO J., 21, 725-735.
22. Matsumoto,K., Nagata,K., Yamanaka,K., Hanaoka,F. and Ui,M. (1989) Nuclear factor I represses the reverse-oriented transcription from the adenovirus type 5 DNA terminus. Biochem. Biophys. Res. Commun., 164, 1212-1219.
23. Hatfield,L. and Hearing,P. (1993) The NFIII/OCT-1 binding site stimulates adenovirus DNA replication in vivo and is functionally redundant with adjacent sequences. J. Virol., 67, 3931-3939.
24. Haruki,H., Gyurcsik,B., Okuwaki,M. and Nagata,K. (2003) Ternary complex formation between DNA-adenovirus core protein VII and TAF-Ibeta/ SET, an acidic molecular chaperone. FEBS Lett., 555, 521-527.
25. Haruki,H., Okuwaki,M., Miyagishi,M., Taira,K. and Nagata,K. (2006) Involvement of template-activating factor I/SET in transcription of adenovirus early genes as a positive-acting factor. J. Virol., 80, 794-801.
26. Gyurcsik,B., Haruki,H., Takahashi,T., Mihara,H. and Nagata,K. (2006) Binding modes of the precursor of adenovirus major core protein VII to DNA and template activating factor I: Implication for the mechanism of remodeling of the adenovirus chromatin. Biochemistry, 45, 303-313.
27. Fedor,M.J. and Daniell,E. (1980) Acetylation of histone-like proteins of adenovirus type 5. J. Virol., 35, 637-643.
28. Taura,K., Yamamoto,Y., Nakajima,A., Hata,K., Uchinami,H., Yonezawa,K., Hatano,E., Nishino,N. and Yamaoka,Y. (2004) Impact of novel histone deacetylase inhibitors, CHAP31 and FR901228 (FK228), on adenovirus-mediated transgene expression. J. Gene. Med., 6, 526-536.
29. Gaetano,C., Catalano,A., Palumbo,R., Illi,B., Orlando,G., Ventoruzzo,G., Serino,F. and Capogrossi,M.C. (2000) Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo. Gene Ther., 7, 1624-1630.
30. Pollard,H., Remy,J.S., Loussouarn,G., Demolombe,S., Behr,J.P. and Escande,D. (1998) Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem. 273, 7507-7511.
31. Zabner,J., Fasbender,A.J., Moninger,T., Poellinger,K.A. and Welsh,M.J. (1995) Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem., 270, 18997-19007.
32. Akita, H., Ito, R., Kamiya, H., Kogure, K. and Harashima, H. Cell-cycle dependent transcription, a determinant factor of heterogeneity in cationic lipid-mediated transgene expression. J. Gene. Med., in press.
33. Price,A., Limberis,M., Gruneich,J.A., Wilson,J.M. and Diamond,S.L. (2005) Targeting viral-mediated transduction to the lung airway epithelium with the anti-inflammatory cationic lipid dexamethasone-spermine. Mol. Ther., 12, 502-509.
34. Hatfield,L. and Hearing,P. (1991) Redundant elements in the adenovirus type 5 inverted terminal repeat promote bidirectional transcription in vitro and are important for virus growth in vivo. Virology, 184, 265-276.
35. Fredman,J.N. and Engler,J.A. (1993) Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro J. Virol., 67, 3384-3395.
36. Schaack,J., Ho,W.Y., Freimuth,P. and Shenk,T. (1990) Adenovirus terminal protein mediates both nuclear matrix association and efficient transcription of adenovirus DNA. Genes Dev., 4, 1197-1208.
37. Martins,R.P., Ostermeier,G.C. and Krawetz,S.A. (2004) Nuclear matrix interactions at the human protamine domain: A working model of potentiation. J. Biol. Chem., 279, 51862-51868.
38. Kamiya,H., Fujimura,Y., Matsuoka,I. and Harashima,H. (2002) Visualization of intracellular trafficking of exogenous DNA delivered by cationic liposomes. Biochem. Biophys. Res. Commun., 298, 591-597.
39. Li,Q.G., Lindman,K. and Wadell,G. (1997) Hydropathic characteristics of adenovirus hexons. Arch. Virol., 142, 1307-1322.
40. Luo,M.L., Zhou,Z., Magni,K., Christoforides,C., Rappsilber,J., Mann,M. and Reed,R. (2001) Pre-mRNA splicing and mRNA export linked by direct interactions between UAP56 and Aly. Nature, 413, 644-647.
41. Strasser,K. and Hurt,E. (2001) Splicing factor Sub2p is required for nuclear mRNA export through its interaction with Yra1p. Nature, 413, 648-652.
42. Strasser,K., Masuda,S., Mason,P., Pfannstiel,J., Oppizzi,M., Rodriguez-Navarro,S., Rondon,A.G., Aguilera,A., Struhl,K. et al. (2002) TREX is a conserved complex coupling transcription with messenger RNA export. Nature, 417, 304-308.